The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease

Mechanisms controlling vascular smooth muscle cell (VSMC) plasticity and renewal still remain to be elucidated completely. A class of small RNAs called microRNAs (miRs) regulate gene expression at the post-transcriptional level. Here, we show a critical role of the miR-143/145 cluster in SMC differentiation and vascular pathogenesis, also through the generation of a mouse model of miR-143 and -145 knockout (KO). We determined that the expression of miR-143 and -145 is decreased in acute and chronic vascular stress (transverse aortic constriction and in aortas of the ApoE KO mouse). In human aortic aneurysms, the expression of miR-143 and -145 was significantly decreased compared with control aortas. In addition, overexpression of miR-143 and -145 decreased neointimal formation in a rat model of acute vascular injury. An in-depth analysis of the miR-143/145 KO mouse model showed that this miR cluster is expressed mostly in the SMC compartment, both during development and postnatally, in vessels and SMC-containing organs. Loss of miR-143 and miR-145 expression induces structural modifications of the aorta, because of an incomplete differentiation of VSMCs. In conclusion, our results show that the miR-143/145 gene cluster has a critical role during SMC differentiation and strongly suggest its involvement in the reversion of the VSMC differentiation phenotype that occurs during vascular disease.

[1]  J. Ross,et al.  ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. , 1994, The American journal of physiology.

[2]  Michael Z Michael,et al.  Reduced accumulation of specific microRNAs in colorectal neoplasia. , 2003, Molecular cancer research : MCR.

[3]  P. Gallagher,et al.  Targeted Expression of SV40 Large T-antigen to Visceral Smooth Muscle Induces Proliferation of Contractile Smooth Muscle Cells and Results in Megacolon* , 1999, The Journal of Biological Chemistry.

[4]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[5]  T. Tuschl,et al.  Identification of Tissue-Specific MicroRNAs from Mouse , 2002, Current Biology.

[6]  Ravi Jain,et al.  MicroRNA-143 Regulates Adipocyte Differentiation* , 2004, Journal of Biological Chemistry.

[7]  E. Goncharova,et al.  Assays for in vitro monitoring of proliferation of human airway smooth muscle (ASM) and human pulmonary arterial vascular smooth muscle (VSM) cells , 2006, Nature Protocols.

[8]  J. D. Smith,et al.  Mouse models of atherosclerosis. , 1998, Laboratory animal science.

[9]  Mark L. Benson,et al.  Isolation of vascular smooth muscle cells from a single murine aorta. , 2001, Methods in cell science : an official journal of the Society for In Vitro Biology.

[10]  C. Sander,et al.  A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.

[11]  H. Horvitz,et al.  MicroRNA Expression in Zebrafish Embryonic Development , 2005, Science.

[12]  P. Tam Faculty Opinions recommendation of miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. , 2009 .

[13]  P. Oettgen,et al.  Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. , 2005, The Journal of clinical investigation.

[14]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[15]  M. Latronico,et al.  MicroRNAs and cardiac pathology , 2009, Nature Reviews Cardiology.

[16]  K. Sobue,et al.  Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation , 2004, Molecular and Cellular Biochemistry.

[17]  G. Owens,et al.  Molecular regulation of vascular smooth muscle cell differentiation in development and disease. , 2004, Physiological reviews.

[18]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[19]  Qiang Zhou,et al.  Ablation of Cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy , 2001, The Journal of cell biology.

[20]  Yukio Kitade,et al.  Downregulation of microRNAs‐143 and ‐145 in B‐cell malignancies , 2007, Cancer science.

[21]  G. Owens,et al.  Regulation of differentiation of vascular smooth muscle cells. , 1995, Physiological reviews.

[22]  A. Palmieri,et al.  Medpor regulates osteoblast's microRNAs. , 2008, Bio-medical materials and engineering.

[23]  G. Condorelli,et al.  Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo , 1995, Nature Medicine.

[24]  Chunxiang Zhang,et al.  MicroRNA Expression Signature and Antisense-Mediated Depletion Reveal an Essential Role of MicroRNA in Vascular Neointimal Lesion Formation , 2007, Circulation research.

[25]  E. Raines PDGF and cardiovascular disease. , 2004, Cytokine & growth factor reviews.

[26]  J. Nemunaitis,et al.  Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? , 2008, Cancer Gene Therapy.

[27]  S. Schwartz Smooth muscle migration in atherosclerosis and restenosis. , 1997, The Journal of clinical investigation.

[28]  Xiaoxia Qi,et al.  Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA , 2007, Science.

[29]  Stefanie Dimmeler,et al.  Role of microRNAs in vascular diseases, inflammation, and angiogenesis. , 2008, Cardiovascular research.

[30]  Chunxiang Zhang,et al.  MicroRNA-145, a Novel Smooth Muscle Cell Phenotypic Marker and Modulator, Controls Vascular Neointimal Lesion Formation , 2009, Circulation research.

[31]  J. Small,et al.  Smooth muscle specific expression of calponin , 1990, FEBS letters.

[32]  H. Augustin,et al.  Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. , 2000, Cancer research.